Lead Exposure Class Certification Splits: Dollar Tree Pouch Class Denied, DuPont Monitoring Class Certified

Two federal courts reached opposite results on lead exposure class certification in the same week: on October 2, 2026, a New York federal judge refused to certify a class of families suing Dollar Tree over lead-tainted WanaBana fruit pouches, while an Indiana federal judge, in an order reported September 30, certified a medical monitoring class of East Chicago children suing DuPont and Hammond Group but refused to certify their personal injury class. Read together, the rulings show where the line now sits: courts will consider a common, forward-looking testing program for a defined exposed population, but they will not adjudicate individual lead poisoning injuries, or a monitoring remedy without a workable common framework, on a class-wide basis.

Neither ruling pays anyone or ends a case. The Dollar Tree families may pursue individual claims, and the East Chicago children's injury claims continue individually alongside the certified monitoring class. What changed is the procedural vehicle, which in lead litigation often decides whether a case is worth bringing at all.

Two lead exposure class certification rulings in three days

The timing is a coincidence, but the contrast is instructive. Both cases involve children. Both involve lead, a toxin for which public health agencies recognize no safe blood level. Both plaintiff groups asked a federal court to certify more than one kind of class, and both ran into the same obstacle on injury: lead poisoning presents differently in every child.

The difference lies in the exposure story. The East Chicago plaintiffs allege years of exposure in a fixed place, the neighborhood around the former USS Lead refinery and the elementary school they attended, to contamination that federal regulators had already mapped. The Dollar Tree plaintiffs allege exposure through a consumer product that each family bought, in different quantities, at different times, in different states, from a retailer that did not make it. A fixed geography with a documented contamination footprint lends itself to common proof. A retail purchase history does not.

For lead exposure class certification, that distinction, more than any difference in legal doctrine between New York and Indiana, explains most of the gap between the two outcomes, at least on the public record available so far.

What happened in the Dollar Tree lead pouch class action?

The New York case arises from the 2023 WanaBana cinnamon applesauce outbreak, one of the largest food-borne lead poisoning events in recent US history. The Food and Drug Administration issued a public health alert on October 28, 2023, and WanaBana recalled its Apple Cinnamon Fruit Puree pouches the next day. Schnucks and Weis cinnamon applesauce products made at the same Ecuadorian plant were recalled as well. The products had been sold nationwide, including through Dollar Tree and Family Dollar combination stores and online.

Investigators traced the lead to cinnamon processed by Austrofood, the Ecuadorian manufacturer, and supplied by a distributor called Negasmart. A class complaint filed in New York in December 2023 pleaded testing that found 2,560 parts per billion of lead in a sample pouch, which it described as 256 times the FDA's 10 ppb action level for fruit purees intended for babies and young children. The FDA's own testing also found chromium in the cinnamon at 1,201 and 531 parts per million in two samples.

The Centers for Disease Control and Prevention's tally reached 519 cases: 136 confirmed, 345 probable, and 38 suspected, spread across 44 states plus Washington, D.C. and Puerto Rico.

Dollar Tree's role came under separate scrutiny. In a warning letter dated June 11, 2024, the FDA said the recalled pouches remained on shelves in several states through late December 2023, roughly two months after the recall. The agency rejected Dollar Tree's reliance on register-level sales blocks as an effective measure, noting that at least one child in Washington state ate a recalled pouch inside a store before an attempted purchase was stopped.

In January 2026, the New York Attorney General announced a $559,250 assurance with Dollar Tree. The office found that Dollar Tree received notice of the recall on the morning of October 29, 2023 but did not immediately stop sales, and that it sold at least 226 three-pack units in New York after that notice, some a full week later through online order pickup. The settlement money goes to lead poisoning prevention and healthy-food access programs, and Dollar Tree agreed to faster recall notification, quicker in-store sales blocks, and recall training for New York store managers.

Against that backdrop, families brought a putative Class Action against Dollar Tree in New York federal court. According to Mealey's account of the October 2 docket order, the plaintiffs sought class treatment both for injury-related claims and for a medical monitoring remedy. The district judge adopted a magistrate judge's report and recommendation over the plaintiffs' objections and denied Class Certification.

Why did the judge deny class certification in the Dollar Tree lead lawsuit?

The court found two independent problems, as reported.

First, individualized issues. The court held that questions about each child's exposure, injuries, and medical history were individual rather than common, which defeats Predominance under Rule 23(b)(3). How many pouches a child ate, when, how much lead was in that lot, what the child's baseline blood lead level was, whether there were other sources of lead in the home, and what symptoms followed: none of these can be answered once for the whole class.

Second, standing and the monitoring framework. The court found that the plaintiffs had not established standing or a workable framework for a medical monitoring class. A monitoring class needs a common answer to what testing the class needs, how often, for how long, and why that testing differs from what a pediatrician would order anyway. Without a defined protocol tied to class-wide proof, a court has nothing common to certify. And after the Supreme Court's 2021 decision in TransUnion LLC v. Ramirez, every class member seeking damages must have suffered a concrete injury; an increased risk of future harm, standing alone, generally does not qualify for a damages claim.

New York law adds a layer. In Caronia v. Philip Morris USA, Inc., 22 N.Y.3d 439 (2013), the New York Court of Appeals held 4-3 that New York does not recognize an independent equitable cause of action for medical monitoring. Monitoring costs remain recoverable as consequential damages, but only once a plaintiff proves an existing tort, which typically requires a physical injury. That rule does not by itself bar a monitoring class, but it ties the monitoring remedy to individual proof of injury, which brings the predominance problem straight back.

The order also arrives after an earlier setback for retailer-focused WanaBana claims. In Smith v. WanaBana, LLC, No. 24-CV-02196 (N.D. Ill. Oct. 31, 2024), a federal court in Illinois dismissed parents' strict liability claim against Dollar Tree on the ground that the retailer did not manufacture the pouches and was protected by the state's non-manufacturer rule, and dismissed their negligence and warranty claims for inadequate pleading, as reported by VitalLaw. Retailers can be harder targets than manufacturers in product cases, and WanaBana LLC itself filed for Chapter 7 in Delaware on May 15, 2024, listing roughly $26 million in liabilities against $500,000 to $1 million in assets. That combination leaves Dollar Tree as the most solvent defendant and explains why plaintiffs pressed so hard on its recall conduct.

What did the court decide in the DuPont East Chicago lead exposure case?

The Indiana case is captioned S.A. v. E.I. du Pont de Nemours and Co., No. 2:22-cv-00359, in the U.S. District Court for the Northern District of Indiana at Hammond. It was brought on behalf of 11 minors who lived in or attended school in the area around the former USS Lead refinery in East Chicago. The defendants named in the certification reports are E.I. du Pont de Nemours and Co. and Hammond Group Inc.

The court granted the certification motion in part and denied it in part. It certified the proposed medical monitoring class and denied certification of the proposed personal injury class, explaining that the plaintiffs "suffer from dozens of different conditions." In other words, the court accepted that exposure in a defined area could be tried on common evidence for purposes of a monitoring remedy, but would not try dozens of different health outcomes as one claim.

That certification followed an earlier skirmish over the class brief itself. Defendants sought judgment against four of the children because the plaintiffs' certification filing described them as having "no injuries confirmed yet." The court declined to treat that phrasing as a binding judicial admission, noting that the same discussion referred to measurable lead in the children's bones. The ruling kept those four children in the case and, in practice, preserved their place in the monitoring class.

The East Chicago site behind the case

The contamination history is long and well documented. According to EPA and public records, a DuPont facility processed metals and chemicals at the site from 1893 to 1912. The Anaconda Copper Company arrived in 1912 and refined lead and produced lead pigment for paint. From 1920 to 1985, the USS Lead plant smelted ore and later, beginning in 1973, recovered lead from batteries and scrap. In 1970, the West Calumet Housing Complex was built on the former Anaconda footprint.

High lead levels were documented at least as early as 1985, but residents were not relocated until 2016, when roughly 1,100 people, about 680 of them children, were ordered out of West Calumet. Carrie Gosch Elementary School, which sat next to the complex, was closed. The area became the USS Lead Superfund Site, and Atlantic Richfield and DuPont agreed with the United States and Indiana to fund the first phase of residential soil cleanup, a settlement the Justice Department valued at $26 million.

That record matters for certification. When a federal agency has already sampled soil yard by yard, plaintiffs can define an exposed population geographically, point to common evidence of contamination, and propose a single testing protocol for everyone who lived or studied inside the boundary.

Dollar Tree vs. DuPont: the two rulings side by side

	Dollar Tree lead pouch case	DuPont / Hammond Group East Chicago case
Court	US District Court, New York (district judge adopting magistrate judge's R&R)	US District Court, N.D. Indiana (Hammond), No. 2:22-cv-00359
Date	Docket order October 2, 2026	Reported September 30, 2026
Exposure source	Recalled WanaBana cinnamon apple pouches bought at retail	Soil and dust around the former USS Lead refinery, West Calumet, Carrie Gosch Elementary
Defendant's role	Retailer; manufacturer WanaBana in Chapter 7	Alleged historical operators and contributors to contamination
Plaintiffs	Families of children who ate the pouches	11 named minors
Medical monitoring class	Denied: no standing or workable monitoring framework shown	Certified
Personal injury class	Denied: individualized exposure, injury, and medical history	Denied: "dozens of different conditions"
Background enforcement	FDA warning letter (June 2024); NY AG $559,250 assurance (January 2026)	EPA Superfund listing; $26 million first-phase cleanup settlement
Next step	Individual claims; possible Rule 23(f) petition	Monitoring class proceeds; injury claims individual

What is a medical monitoring class, and why did it survive in Indiana but not New York?

A medical monitoring class asks a court to order a defendant to fund periodic diagnostic testing for people exposed to a toxin, so that disease can be caught early. The theory is that the need for testing is itself a common consequence of exposure, even before anyone is diagnosed with anything. Courts that accept the theory typically require proof of significant exposure to a proven hazardous substance through the defendant's conduct, an increased risk of serious disease, a monitoring regimen that makes early detection possible, and testing that is different from what a doctor would normally recommend.

Those elements are designed to be proved with common evidence: one exposure model, one toxicology opinion, one testing protocol. That is why monitoring classes are sometimes certified under Rule 23(b)(2) as equitable relief, or under Rule 23(b)(3) when the common questions predominate. The Supreme Court's decision in Wal-Mart Stores, Inc. v. Dukes (2011) narrowed the (b)(2) route to indivisible injunctive or declaratory relief, so plaintiffs increasingly frame monitoring as a court-supervised program rather than a cash payment to each class member.

States differ on whether a monitoring claim exists at all. New York, under Caronia, allows monitoring only as damages on a proven tort. Missouri took the opposite approach in Meyer ex rel. Coplin v. Fluor Corp., 220 S.W.3d 712 (Mo. 2007), where the state Supreme Court reversed the denial of a monitoring class of children exposed to lead from a smelter in Herculaneum, finding that common issues predominated. The available reports on the Indiana order do not spell out the precise legal theory supporting the monitoring class, and this article does not speculate on it.

The practical differences between the two cases are easier to see:

• Defined population. East Chicago residents and Carrie Gosch students form a bounded group tied to mapped contamination. Pouch buyers are scattered across 44 states and identified only by purchase and consumption history.
• Exposure proof. Soil sampling and the site's regulatory record provide a common exposure baseline. Pouch exposure depends on how many pouches a child ate and from which lot, which is individual by nature.
• Duration. Chronic, years-long residential and school exposure supports a forward-looking testing program. A short dietary exposure that ended with the recall makes the case for long-term common monitoring harder to articulate.
• Defendant. A historical operator of the contaminating site is a natural funder of a site-wide program. A retailer that resold a product made by a now-bankrupt manufacturer is not.

Why are personal injury classes rarely certified in lead exposure cases?

Both judges denied the personal injury class, and in lead exposure class certification fights that result is the norm, not the exception. Since Amchem Products, Inc. v. Windsor (1997), federal courts have been skeptical that individual bodily injury claims from a toxic exposure can satisfy predominance. Each plaintiff must prove Specific Causation: that this exposure, rather than another source, caused this child's particular condition, at this severity. Lead effects range from developmental delay and attention problems to anemia and gastrointestinal symptoms, and many of those conditions have other common causes.

Damages vary just as widely, and Comcast Corp. v. Behrend (2013) requires a damages model that measures harm consistently with the plaintiffs' theory of liability across the class. The Indiana court's phrase, that the plaintiffs "suffer from dozens of different conditions," captures the problem in six words. The New York court's emphasis on each child's exposure, injuries, and medical history says the same thing in a consumer product setting.

General Causation, whether lead can cause a given condition at all, is usually a common question and can be tried once. Specific causation and damages almost never can. That is why lead and other toxic tort litigation typically proceeds through individual suits, state-court consolidations, or, where volume justifies it, Multidistrict Litigation (MDL), rather than a personal injury class.

Standing after TransUnion: the exposure-only problem

The New York court's standing finding connects to a line of cases that has made exposure-only monitoring classes harder to sustain in federal court. In Tiger v. Verizon Communications Inc., 2025 WL 437019 (W.D. Pa. Feb. 7, 2025), a federal court dismissed an occupational lead exposure monitoring class brought by a utility pole worker who alleged exposure to lead-sheathed telecommunications cables. The court called the allegations "too conjectural and speculative," pointing to "naturally occurring lead levels in the environment and in our bodies," and rejected the theory that exposure alone is an injury because no level of lead is safe.

The East Chicago plaintiffs avoided that trap, at least at certification, by pleading measurable lead in the children's bones and long-term exposure at a documented site. The Dollar Tree plaintiffs, as described in the reports, did not persuade the court that every class member had a concrete injury or that a common monitoring protocol could be designed. For plaintiffs' counsel, the lesson is that biomarker evidence and a defined exposure footprint are no longer optional in a federal monitoring class.

What it means for plaintiffs' counsel, defendants, and families

For plaintiffs' counsel. Product-based lead cases against retailers face a steep lead exposure class certification climb. The more promising vehicle is likely individual or consolidated injury claims, with careful case selection around documented blood lead levels and medical records. Where a defined contamination site exists, a monitoring class remains viable if it is built on biomarker evidence, a specific testing protocol, and an exposure boundary drawn from regulatory sampling. Pleading language matters: the East Chicago "no injuries confirmed yet" episode shows how a class brief can be used against named plaintiffs.

For defendants. The Dollar Tree ruling gives retailers a roadmap: attack the absence of a uniform exposure measure, the lack of a concrete injury for every class member, and the vagueness of the proposed monitoring regime. Site-contamination defendants face a different calculation. Once a monitoring class is certified, exposure to a court-supervised testing program that may run for years becomes real, and the leverage shifts toward a negotiated program or a Global Settlement covering both monitoring and individual injury claims.

For families. Denial of certification in the Dollar Tree case does not decide whether any child was harmed or whether Dollar Tree is liable. Families with children who ate the recalled pouches can still bring individual claims, subject to each state's Statute of Limitations, which for minors is often tolled until adulthood but varies by state. In East Chicago, children within the certified class definition may become eligible for a monitoring program if the plaintiffs ultimately prevail or settle, while any claim for an actual injury still has to be proved individually.

For mass tort practices and funders. The pair of lead exposure class certification rulings reinforces that lead cases are valued on documented injury, not exposure alone. Firms evaluating lead dockets, including the newer wave of consumer lead cases over spices, tampons, and children's products, should expect courts to demand individual proof early.

Can WanaBana lead pouch victims still sue Dollar Tree individually?

Yes. A denial of class certification ends only the attempt to litigate on a class-wide basis. Each family's own claim survives and can be pursued individually, either in the same court or in state court, subject to deadlines and to defenses such as the non-manufacturer rules that helped Dollar Tree defeat strict liability claims in Illinois. Because WanaBana LLC is in Chapter 7, claims against the manufacturer itself run through the bankruptcy estate rather than ordinary litigation.

What happens next in both cases

Under Rule 23(f), a party may petition the relevant court of appeals for permission to appeal a class certification order within 14 days after it is entered. In the Dollar Tree case, that would mean the Second Circuit; in the East Chicago case, the Seventh Circuit. Courts of appeals grant such petitions sparingly. Absent an appeal, the Dollar Tree matter proceeds on the named plaintiffs' individual claims, and the East Chicago monitoring class moves toward notice, merits discovery, and expert work on the scope and duration of testing.

A defendant facing a certified monitoring class may also seek to narrow the class definition, challenge the monitoring protocol under Rule 702, or move to decertify if the evidence develops differently from what was presented at certification.

Stage	Dollar Tree case	East Chicago case
Certification order	October 2, 2026	Reported September 30, 2026
Rule 23(f) window	14 days from entry	14 days from entry
Class notice	None (no class)	To follow if order stands
Individual injury claims	Continue for named plaintiffs	Continue outside the class

Lead exposure class certification: frequently asked questions

What happened in the Dollar Tree lead pouch class action?

On October 2, 2026, a federal judge in New York denied class certification in a lawsuit alleging Dollar Tree sold lead-contaminated WanaBana fruit pouches, adopting a magistrate judge's recommendation. The court found each child's exposure, injuries, and medical history too individualized for class treatment.

Why did the judge deny class certification in the Dollar Tree lead lawsuit?

The court found that individual questions about each child's exposure, injury, and medical history predominated over common ones, and that the plaintiffs had not shown standing or a workable framework for a medical monitoring class.

What did the court decide in the DuPont East Chicago lead exposure case?

The U.S. District Court for the Northern District of Indiana certified a medical monitoring class of East Chicago children suing DuPont and Hammond Group, but denied a personal injury class because the plaintiffs "suffer from dozens of different conditions."

Is there a WanaBana or Dollar Tree lead settlement?

No class settlement or claim form exists for WanaBana pouch injuries. The only resolution involving Dollar Tree so far is the New York Attorney General's $559,250 assurance announced in January 2026, which funds public programs and recall reforms rather than paying individual families.

Does the DuPont ruling mean East Chicago families will get paid?

Not directly. Certification of a medical monitoring class means the plaintiffs can seek a court-supervised testing program for the class; it is not a damages award. Personal injury compensation, if any, must still be proved child by child.

Why are personal injury classes rarely certified in lead exposure cases?

Because each plaintiff must prove that lead from the defendant, rather than another source, caused that person's particular condition, and damages vary from child to child. Those individual issues usually defeat Rule 23(b)(3) predominance.